AGM Information • Jun 20, 2024
AGM Information
Open in ViewerOpens in native device viewer
This document is important and requires your immediate attention. If you are in any doubt as to what action you should take, you are recommended to seek your own independent advice from your stockbroker, solicitor, accountant or other professional adviser immediately. If you have sold or transferred all of your discoverIE Group plc ordinary shares, please forward this document, together with the accompanying documents, as soon as possible to the purchaser or transferee or to the agent through whom the sale or transfer was effected for delivery to the purchaser or transferee.
Notice of Annual General Meeting and Chairman's explanatory letter
20 June 2024
Dear Shareholder,
I am pleased to write to you with the arrangements for the Annual General Meeting (the "Meeting") of discoverIE Group plc (the "Company") to be held at 2 Chancellor Court, Occam Road, Surrey Research Park, Guildford, Surrey GU2 7AH at 11.30 am on Friday 26 July 2024.
You will find with this letter:
Your Directors believe that all the proposals to be considered at the Meeting are in the best interests of the Company and of its shareholders as a whole. They recommend that you vote in favour of the resolutions to be put to you at the Meeting, as they intend to do in respect of their own beneficial holdings.
You are requested to complete, sign and return the Form of Proxy, in accordance with the directions, as soon as possible and, in any event, so that it is received by 11.30 am on Wednesday 24 July 2024 (or in the event of any adjournment, 48 hours (excluding non-working days) before the time of the adjourned meeting). Completion and return of the Form of Proxy will not prevent you from attending the Meeting and voting in person, should you wish to do so. Should you have any questions please contact Greg Davidson, Group General Counsel & Company Secretary, at [email protected].
We will keep you updated with any necessary changes to the arrangements in due course via our website and our market announcements.
Yours faithfully
Bruce Thompson (Chairman)
discoverIE Group plc, 2 Chancellor Court, Occam Road, Surrey Research Park, Guildford, Surrey GU2 7AH
Tel: +44(0)1483 544500
Registered office as above. Registered No: 2008246 England & Wales
NOTICE IS HEREBY GIVEN of the Annual General Meeting (the "Meeting") of discoverIE Group plc (the "Company") to be held at 2 Chancellor Court, Occam Road, Surrey Research Park, Guildford, Surrey GU2 7AH on Friday 26 July 2024 at 11.30 am to consider and, if thought fit, to pass the Resolutions set out below.
Resolutions 1 to 14 and 21 to 23 will be proposed as Ordinary Resolutions while Resolutions 15 to 20 will be proposed as Special Resolutions.
For the purpose of this Resolution a "pre-emptive offer" means an offer to:
to subscribe for further securities by means of the crediting of entitlements to subscribe or entitlements to rights or the issue of an application form or renounceable letter, but subject to such exclusions or other arrangements as the Directors may deem necessary or expedient in relation to treasury shares, fractional entitlements, record dates or legal, regulatory or practical problems in, or under the laws of, any territory, or any other matter.
such authorities to apply until the earlier of the date of the Company's next Annual General Meeting or 25 October 2025 save that the Company may, before such expiry, make an offer or agreement which would or might require equity securities to be allotted or treasury shares to be sold after such expiry and the Directors may allot equity securities and sell treasury shares in pursuance of such an offer or agreement, as if the power conferred hereby had not expired.
such authorities to apply until the earlier of the date of the Company's next Annual General Meeting or 25 October 2025 save that the Company may, before such expiry, make an offer or agreement which would or might require equity securities to be allotted or treasury shares to be sold after such expiry and the Board may allot equity securities and sell treasury shares in pursuance of such an offer or agreement, as if the power conferred hereby had not expired.
18 That, subject to the passing of Resolution 15 above, the Directors be and are hereby empowered pursuant to Section 570 of the Companies Act 2006 to allot equity securities (within the meaning of Section 560 of the said Act) for cash pursuant to the authority conferred by Resolution 15 above as if sub-section (1) of Section 561 of the said Act did not apply to any such allotment, provided that this power shall expire on the earlier of the date of the Company's next Annual General Meeting or 25 October 2025 save that the Company may before such expiry make an offer or agreement which would or might require equity securities to be allotted or treasury shares to be sold after such expiry and the Board may allot equity securities and sell treasury shares in pursuance of such an offer or agreement as if the power conferred hereby had not expired.
during the period beginning on the date of this Resolution and ending at the conclusion of the Company's next Annual General Meeting or, if earlier, on 25 October 2025.
For the purposes of this Resolution, 'political donation', 'political parties', 'independent election candidates', 'political organisation' and 'political expenditure' have the meanings given to them in Part 14 of the Companies Act 2006.
By Order of the Board
Group General Counsel & Company Secretary Registered Office 2 Chancellor Court, Occam Road, Surrey Research Park, Guildford, Surrey GU2 7AH
20 June 2024
* A scanned copy of any power of attorney or other authority (if any) under which the appointment is made must also be sent by email.
In accordance with the Companies Act 2006 (the "Act"), the Directors must present to the Meeting the Financial Statements of discoverIE Group plc (the "Company") for the year ended 31 March 2024, together with the Reports of the Directors and the Auditor thereon and the Directors' Remuneration Report with the associated Auditor's Report. These are contained in the Company's Annual Report and Accounts.
A final dividend can only be paid after it has been approved by the shareholders and cannot exceed the amount recommended by the Board. A final dividend of 8.25 pence per ordinary share is recommended for payment by the Board to the shareholders who are entered in the register of members of the Company at the close of business on 28 June 2024 and, if approved, the date of payment of the final dividend will be 2 August 2024.
The Company is seeking shareholders' approval of the Directors' Remuneration Report (other than the Directors' Remuneration Policy) under Resolution 3.
The Directors are required to prepare the Directors' Remuneration Report which is set out on pages 113 to 138 of the Annual Report and Accounts. The Directors' Remuneration Report comprises an annual report detailing the remuneration of the directors and a statement by the Chair of the Remuneration Committee. The Company is required to seek Shareholders' approval in respect of the contents of this report on an annual basis. The vote is an advisory one, and no entitlement of a Director to remuneration is conditional on it. The Company's auditor, PricewaterhouseCoopers LLP, has audited those parts of the Directors' Remuneration Report that are required to be audited.
Shareholders are separately asked to approve the new Directors' Remuneration Policy which is set out on pages 118 to 127 of the Annual Report and Accounts.
It is intended that this will take effect immediately after the Meeting and will replace the existing policy that was approved by shareholders in July 2021. It is anticipated that the Directors' Remuneration Policy will be in force for three years although the Company will closely monitor regulatory changes and market trends and, if necessary, may present a revised policy within that three-year period.
The Directors' Remuneration Policy has been developed taking into account the principles of the UK Corporate Governance Code and the views of the Company's major shareholders.
The Company has adopted the provisions of the 2018 UK Corporate Governance Code regarding the annual election of Directors and therefore each of the existing Directors of the Company are required to stand for election or re-election, as relevant, at the Annual General Meeting.
Biographical details for each Director can be found on pages 86 to 87 of the Annual Report and Accounts and on the Company's website www.discoverIEplc.com.
Details of Board activity during the year and the Board Evaluation process can be found in the Corporate Governance Report on pages 88 to 99 of the Annual Report and Accounts. Having considered the skills and experience and the performance of, and contribution made by, each Director, and the independence of each Non-Executive Director, the Board is satisfied that all Directors continue to be effective and continue to demonstrate a great deal of commitment to their roles and that their respective skills complement each other to enhance the overall operation of the Board of Directors. Through their ongoing consideration of strategic, operational, financial and risk matters, and by providing appropriate challenge to management, the Board considers that all Directors continue to make an important contribution to the long-term sustainable success of the Company. As such, the Board unanimously recommends their re-election.
The Company is required to appoint an external auditor at each general meeting at which accounts are laid before the Company, to hold office from the conclusion of that general meeting until the conclusion of the next general meeting.
PricewaterhouseCoopers LLP have resigned as the statutory auditors of the Company following a formal tender process led by the Audit and Risk Committee and the Board has appointed Deloitte LLP to fill the vacancy.
Deloitte LLP have indicated their willingness to be appointed as the Company's statutory auditors and the Board, on the recommendation of the Audit and Risk Committee, is proposing to shareholders the appointment of Deloitte LLP as statutory auditors for the year ending 31 March 2025.
Accordingly, resolution 12 proposes the appointment of Deloitte LLP as the Company's auditors to hold office until the conclusion of the next general meeting of the Company at which accounts are laid before the meeting.
Further, resolution 13 seeks the authority for the Directors, acting through the Audit and Risk Committee, be authorised to determine the auditor's remuneration.
The Act requires that, to allot unissued shares, the Directors must receive authority from shareholders. The Company's Articles of Association give a general authority to the Directors to allot unissued shares, which is subject to renewal by shareholders.
This Resolution will allow the Directors to issue new shares up to a total nominal value of £1,605,935 (the Section 551 Amount) which represents approximately one-third of the Company's issued share capital (calculated exclusive of any treasury shares). This authority will expire on the earlier of the date of the Company's next Annual General Meeting or 25 October 2025. As at 19 June 2024, the Company did not hold any treasury shares within the meaning of Section 724(5) of the Act.
The Directors have no present intention of exercising this authority but, as in previous years, consider it desirable that they should have the flexibility to issue new shares from time to time to enable the Company to act in the best interests of shareholders, when opportunities arise. However, the Directors will contemplate using this authority to take advantage of targeted acquisitions that help deliver the Company's strategy.
These Resolutions authorise the Directors to allot, in addition to the authority referred to in Resolution 14, up to a further nominal amount of £1,605,935 in connection with a pre-emptive offer to existing shareholders, without the need to comply with the strict requirements of the statutory pre-emption provisions. This is in accordance with guidance on directors' powers to allot shares published by the Investment Association.
The guidance states that Investment Association members would support resolutions authorising the allotment of an additional one-third of the issued ordinary share capital provided that the additional authority can only be used for fully preemptive offers.
The Directors have no present intention to make use of these authorities (which will expire on the earlier of the date of the Company's next Annual General Meeting or 25 October 2025), but as in previous years, consider it desirable that they should have the flexibility to act in the best interests of shareholders when opportunities arise. They will contemplate using the authorities to take advantage of targeted acquisitions that help deliver the Company's strategy.
The Act requires that, subject to certain exceptions, before directors of a company can issue any new shares (including the sale of treasury shares) for cash, the new shares must first be offered to existing members of the Company in proportion to the number of shares which they hold at the time of the offer.
The Company's Articles of Association give a general authority to the Directors so that this statutory pre-emption requirement does not apply to allotments of shares or the sale of treasury shares for cash up to a specific amount, which is subject to renewal by shareholders.
In addition to and without prejudice to the authority in Resolution 15, this Resolution would allow the Directors to allot shares or sell treasury shares for cash only pursuant to the authority conferred by Resolution 14 up to a nominal value of £481,780 (the Section 561 Amount) which is approximately ten per cent. of the Company's issued share capital (calculated inclusive of treasury shares).
Resolution 16 also provides the Directors with the power to disapply pre-emption rights up to an aggregate nominal amount equal to 20% of any allotments or sales which are subject to Article 7.5 of the Company's articles of association, to be used only for the purposes of making a follow-on offer of the kind contemplated by paragraph 3 of Section 2B of the Pre-Emption Group's latest November 2022 Statement of Principles ("Statement of Principles").
This resolution means that the rights of existing shareholders are protected. If a share issue is not a pre-emptive offer, the proportionate interest of existing shareholders could not, without their agreement, be reduced under this resolution by more than twelve per cent. by the issue of new shares or the sale of treasury shares for cash to new shareholders. Such authority would expire on the earlier of the date of the Company's next Annual General Meeting or 25 October 2025. Again, the Directors have no present intention of exercising this authority but, as in previous years, consider it desirable that they should have the flexibility to act in the best interests of shareholders when opportunities arise. They will contemplate using the authorities to take advantage of targeted acquisitions that help deliver the Company's strategy.
In addition to the authority conferred by Resolution 16, the authority conferred by Resolution 17 allows the Directors to allot shares or sell treasury shares for cash on a non pre-emptive basis up to a nominal value of 481,780, being approximately ten per cent. of the Company's issued share capital (calculated inclusive of treasury shares).
Resolution 17 also provides the Directors with the power to disapply pre-emption rights up to an aggregate nominal amount equal to 20% of any allotments or sales under paragraph (a) of resolution 17, to be used only for the purposes of making a follow-on offer of the kind contemplated by paragraph 3 of Section 2B of the Statement of Principles.
The additional authority conferred by Resolution 17 reflects the Statement of Principles for the disapplication of pre-emption rights. The Directors will have due regard to the Statement of Principles in relation to any exercise of this power. The Directors confirm that they intend to use this power only in connection with an acquisition or specified capital investment (within the meaning of the Statement of Principles from time to time) which is announced contemporaneously with the issue, or which has taken place in the preceding twelve month period and is disclosed in the announcement of the issue.
Together, Resolutions 16 and 17 will allow the Directors to allot shares or sell treasury shares for cash on a non pre-emptive basis up to a maximum nominal value of £1,156,273, being approximately twenty four per cent. of the Company's issued share capital (calculated inclusive of treasury shares) if all authorities under Resolutions 16 and 17 were used for non-pre-emptive issues and follow-on offers. Such authorities would expire on the earlier of the date of the Company's next Annual General Meeting or 25 October 2025.
The Act requires that a company must be authorised by its shareholders for it to purchase its own shares. The Company's Articles of Association contain a provision allowing the Directors to purchase the Company's own shares, subject to the prior authority of the shareholders having been obtained. This Resolution seeks authority for the Company to make market purchases of its own shares within the limits set out.
The Directors are of the opinion that it would be advantageous for the Company to be in a position to purchase its own shares through the London Stock Exchange should market conditions and price justify that action. The proposed authority would enable the Company to purchase up to a maximum of 9,635,610 ordinary shares of five pence each in the capital of the Company (which represents approximately 10 per cent. of the Company's share capital), with a stated upper limit on the price payable, which reflects the requirements of the Listing Rules. Purchases would only be made after the most careful consideration, where the Directors believed that an increase in earnings or net assets per share would result and where purchases were, in the opinion of the Directors, in the best interests of the Company and its shareholders. The Directors consider that it is prudent to obtain the proposed authority, although they do not currently intend to exercise it.
The Act permits companies to hold any shares acquired by way of market purchases in treasury rather than having to cancel them. The Company would consider holding any of its own shares purchased under the authority granted by Resolution 18 as treasury shares. This would give the Company the ability to re-issue treasury shares, as and when required, quickly and cost effectively and would provide the Company with additional flexibility in the management of its capital base. No dividends would be paid on shares while held in treasury and no voting rights would attach to those shares.
Due to changes in the law made by the implementation of the Companies (Shareholders' Rights) Regulations 2009, listed companies must call general meetings (other than an annual general meeting) on at least 21 clear days' notice unless the company:
To enable the Company to continue to utilise the shorter notice period of 14 clear days for calling such general meetings, shareholders are being asked to approve this Resolution. The shorter notice period would not be used as a matter of routine for such meetings, but only where the flexibility is merited by the business of the meeting and is thought to be to the advantage of shareholders as a whole. If granted, this authority will be effective until the Company's next Annual General Meeting. This is the same authority which was sought and granted at previous Annual General Meetings.
The Company does not currently make donations to political organisations or incur political expenditure, as those expressions are commonly understood, and has no intention of doing so or using the authority of Resolution 21 to do so.
The Act places restrictions on companies from making political donations or political expenditure. Those expressions are widely defined in the Act and could potentially cover spending on organisations concerned with policy review and law reform, or representation of the business community, which the Company and its subsidiaries might wish to support.
To allow the Company and its subsidiaries to do so and to avoid the possibility of inadvertently breaching the Act, the Company is seeking to allow the Company and its subsidiaries to make donations up to a limit of £100,000 and incur expenditure up to a limit of £100,000.
This authority is sought for a period of one year, until the date of the next Annual General Meeting or, if earlier, on 25 October 2025.
Any political donation or political expenditure made or incurred under the authority of this Resolution will be disclosed in next year's annual report and accounts.
1) Interaction of post-cessation shareholding and LTIP holding periods
At the last Remuneration Policy renewal, a two-year post cessation shareholding guideline based on 200% of base salary for all Executive Directors was introduced.
The Remuneration Committee has recommended that shareholding requirements post cessation of employment be simplified to ensure there is an appropriate and proportionate level of alignment after an Executive Director ceases to be an office holder.
Accordingly, it is proposed that, for good leavers, LTIP awards will normally vest on their normal vesting dates with holding periods expiring on the earlier of their normal two-year expiry or the second anniversary of ceasing to be a director.
The current LTIP grant levels for the CEO and CFO are 175% and 160% of salary with a Remuneration Policy limit of 175% of salary.
Reflecting the performance of the business and the executives, along with the business' increased scale and complexity, the Remuneration Committee has proposed to increase the overall LTIP Policy limit to 200% of base salary to incorporate additional headroom over the life of the Policy. However, LTIP awards will be made at the currently prevailing 175% and 160% of salary levels in 2024/25.
The Remuneration Committee will continue to consider the performance of the business and the year-on-year change in share price when determining the size of the LTIP award, within the approved Policy limits, to be granted each year to the Executive Directors.
During the course of the last year, the Remuneration Committee has reviewed the Company's bonus deferral arrangements and noted that the method of deferral and proportion deferred are out of line with good and typical practice. Currently, 20% of the net of tax bonus is deferred in shares. Under this structure personal tax is paid upfront and these shares become wholly owned by the executives and therefore are not subject to forfeiture.
The Remuneration Committee has concluded that shareholder authority should be sought under Resolution 23 for a new arrangement, the discoverIE Group plc 2024 Deferred Share Bonus Plan (the "2024 DSBP").
The terms of the 2024 DSBP have been designed to provide that, going forward, the Company's bonus deferral arrangements shall be granted as a share award (in the form of nil cost options) which vest after three years. Awards may be exercised after three years and personal tax will be due on the date of exercise. Each award will be subject to good and bad leaver provisions as well as malus until the point of vesting.
Current executives have significant shareholdings with the CEO and CFO holding shares with values of over 1,800% and 870% of their respective base salaries. Their shareholding guideline is set at 250% of base salary, which is higher than typical market levels. The Remuneration Committee recognises that other companies may adopt a higher bonus deferral but also appreciates the significant equity stakes held by the management team. As a result, the Remuneration Committee is proposing to increase bonus deferral to 33.3% of bonus but only in cases where an executive's shareholding is below his or her shareholding guideline. For those holding shares at or higher than the shareholding guideline, deferral will continue to be 20% of bonus earned.
A summary of the principal terms of the 2024 DSBP is set out in Appendix 1 to this Notice.
The Remuneration Committee will supervise the operation of the 2024 DSBP. Any employee (including an Executive Director) of the Company and its subsidiaries will be eligible to participate in the DSBP at the discretion of the Remuneration Committee.
The DSBP is intended to facilitate the deferral of a portion of any annual bonus which is otherwise payable to selected employees of the Group (including Executive Directors) into awards over fully paid ordinary shares in the capital of the Company (Ordinary Shares). The DSBP has been designed to align with prevailing best practice and the terms of the Company's Directors' Remuneration Policy.
Words in this Appendix 1 shall have the meaning set out in the rules of the DSBP except where otherwise defined in Appendix 1 or in the Notice to which this Appendix 1 is attached.
All employees (including Executive Directors) of the Company and any other Group Member (together, the "Group") are eligible to participate in the DSBP and receive awards at the discretion of the Remuneration Committee.
The DSBP will primarily be operated to defer the bonuses of Executive Directors. However, the Remuneration Committee may select other employees of the Group to participate in the DSBP at its discretion.
The Remuneration Committee may grant awards to acquire Ordinary Shares as conditional share awards or as nil cost options. The Remuneration Committee may also decide to grant cash-based awards of an equivalent value to share-based awards or to satisfy share-based awards in cash, although it does not currently intend to do so.
The Remuneration Committee may grant awards within six weeks of the adoption of the 2024 DSBP. Thereafter, the Remuneration Committee may grant awards within 90 days following the Company's announcement of its results for any period. The Remuneration Committee may also grant awards at any other time when it considers there to be exceptional circumstances which justify the granting of awards.
An award may not be granted more than 10 years after the date on which the 2024 DSBP is adopted.
No payment is required for the grant of an award. Awards are not transferable, except on death. Awards are not pensionable.
The vesting of awards will be subject to a minimum vesting period but will not be subject to the achievement of any performance conditions.
Awards shall ordinarily vest on such normal vesting date specified for the award. The normal vesting date in respect of awards to Executive Directors shall be the third anniversary of the grant of the award.
Where awards are granted in the form of options, once exercisable these will then remain exercisable up until the tenth anniversary of grant (or such shorter period specified by the Remuneration Committee at the time of grant) unless they lapse earlier. Shorter exercise periods shall apply in the case of ''good leavers'' and/or vesting of awards in connection with corporate events (see below).
As a general rule, an award will lapse upon a participant's termination of employment within the Group.
However, if a participant ceases to be an employee of the Group because of death, injury, ill-health, disability, redundancy, retirement with the agreement of the Remuneration Committee, their employing company or the business for which they work being sold out of the Group or in other circumstances at the discretion of the Remuneration Committee, then their award will vest on the earlier of (a) their normal vesting date, and (b) the second anniversary of ceasing to be an employee (except in the case of death, when the award will vest on the date of death).
A vested award in the form of an option shall continue to be exercisable for a 12-month period commencing on the date of termination of employment (or, if shorter, until the expiry of the normal exercise period) or such other period that the Committee specifies and, to the extent that the Option is not exercised, it shall lapse at the end of that period.
In the event of a takeover or winding up of the Company (not being an internal corporate reorganisation) all awards will vest early.
In the event of an internal corporate reorganisation, awards will be replaced by equivalent new awards over shares in a new holding company.
In the event of a demerger, special dividend or other similar event which, in the opinion of the Remuneration Committee, would affect the market price of the Ordinary Shares to a material extent, the Remuneration Committee may decide that awards shall vest early or be adjusted on such basis as considered appropriate.
Once vested, awards will not be subject to any subsequent holding periods.
The Remuneration Committee may decide that participants will receive a payment (in cash and/or Ordinary Shares) on or shortly following the vesting/exercise of their awards of an amount equivalent to the dividends that would have been paid on the award's number of vested Ordinary Shares between the time (or part of the time) when the awards were granted and the time when they vest (or where an award is structured as an option, the date of exercise of such award). This amount may assume the reinvestment of dividends. Alternatively, participants may have their awards increased as if dividends were paid on the Ordinary Shares subject to their award and then assumed to be reinvested in further Ordinary Shares.
The Remuneration Committee may apply the DSBP's malus and clawback provisions if, at any point prior to the vesting of an award, it is discovered that there has been a material misstatement of the Company's financial results, an error of calculation (including on account of inaccurate or misleading information) or in the event of serious misconduct, material reputational damage or corporate failure.
The malus and clawback may be satisfied by way of a reduction in the amount of any future bonus, existing award or future share awards and/or a requirement to make a cash payment.
Awards will not confer any shareholder rights until the awards have vested or the options have been exercised, as relevant, and the participants have received their Ordinary Shares.
Any Ordinary Shares allotted will rank equally with Ordinary Shares then in issue (except for rights arising by reference to a record date prior to their allotment).
In the event of any variation of the Company's share capital or in the event of a demerger, payment of a special dividend or similar event which materially affects the market price of the Ordinary Shares, the Remuneration Committee may make such adjustment as it considers appropriate to the number of Ordinary Shares subject to an award.
The DSBP may operate over new issue shares, treasury shares or shares purchased in the market.
In any ten calendar year period, the Company may not issue (or grant rights to issue) more than 10% of the issued ordinary share capital of the Company under the DSBP and any other (executive or otherwise) share incentive plan adopted by the Company.
Treasury shares will count as new issue shares for the purposes of such limit unless institutional investor guidelines cease to require them to count.
The Remuneration Committee may, at any time, amend the DSBP in any respect, provided that the prior approval of Shareholders is obtained for any amendments that are to the advantage of participants in respect of the rules governing eligibility, limits on participation, the overall limits on the issue of shares or the transfer of treasury shares, the basis for determining a participant's entitlement to, and the terms of, the shares or cash to be acquired and the adjustment of awards.
The requirement to obtain the prior approval of Shareholders will not, however, apply to any minor alteration made to benefit the administration of the DSBP, to take account of a change in legislation or to obtain or maintain favourable tax, exchange control or regulatory treatment for participants or for any company in the Group. Shareholder approval will also not be required for any amendments to any performance condition applying to an award amended in line with its terms.
The shareholder resolution to approve the DSBP will allow the Board to establish further plans for overseas territories, any such plan to be similar to the DSBP, but modified to take account of local tax, exchange control or securities laws, provided that any shares made available under such further plans are treated as counting against the limits on individual and overall participation in the plans.
2 Chancellor Court Occam Road Surrey Research Park Guildford Surrey GU2 7AH
Telephone +44 (0)1483 544500
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.